Innovaderm continues use of Medrio’s EDC for dermatology trials

By Maggie Lynch

- Last updated on GMT

(Image: Getty/	Hoxton/Tom Merton)
(Image: Getty/ Hoxton/Tom Merton)

Related tags Edc Clinical trials Clinical research Data management Dermatology Software eclinical

Innovaderm inks deal to extend its use of Medrio’s cloud-based EDC technology for early-phase dermatology clinical trials through 2023.

The specialty contract research organization (CRO) focused on dermatology, Innovaderm, has been a client of Medrio eClinical software for over 9 years, using its software in Phase I, IIa, and IIb studies.  

The new agreement will see Innovaderm continue its use of Medrio’s eClinical software platforms, including: eSource, eConsent, and ePro, until 2023.

All of these eClinical software platforms are designed for the use in early-phase pharma clinical research, and  include electronic data capture (EDC), which Innovaderm cited as part of the reason for continuing the partnership. “Organizations conducting all types of clinical trials use EDC to build study databases, store data electronically, detect and resolve data entry errors, run reports on their data, and more. The reason Medrio is particularly well-suited to early phase pharma trials has to do with simplicity and cost,”​ a company spokesperson told us.

The spokesperson explained that a platform with cloud-based EDC is a fit for early phase trials due to the needs of those studies, “Early phase trials typically use more straightforward study designs and often require mid-study changes to the database, and this goes hand-in-hand with Medrio enabling users to build studies on their own without any programming, which many other EDCs require, and easily make mid-study changes on the fly.”

Medrio’s eConsent was added to the company’s eClinical software platform in November 2018 as a way to provide clients with an electronic-consent application​ to accelerate clinical trial processes. The cloud-based platform enables sponsors and CROs to access consent forms instantly. 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Webinars

Headlines